COPDF Congratulates Boehringer Ingelheim and Biosector 2 for 'Best Use of Social Media' Award
The COPD Foundation is delighted to congratulate Boehringer Ingelheim Pharmaceuticals and Biosector 2 for winning Medical Marketing and Media’s “Best Use of Social Media” Gold Award for the incredible success of DRIVE4COPD.
This award recognizes “excellence from digital initiatives, targeting either consumers/patients or healthcare professionals that use social media channels such as Facebook, Twitter and YouTube.”
As a partner in DRIVE4COPD—the nation's single largest awareness campaign for chronic obstructive pulmonary disease (COPD)—the COPD Foundation notes all the accomplishments of the campaign since its inception in February 2010:
• Screening two million Americans at risk for COPD since the launch in February 2010 using the Population Screener —twice the number anticipated.
• Generating a robust social media campaign reaching millions through viral marketing—with 58,325 Twitter followers, 4,000+ Facebook fans, and 10,600+ YouTube views.
• Distributing news to thousands of media outlets across the country—with Public Service Announcements reaching nearly a billion listeners.
• Solidifying partnerships with high-profile organizations such as NASCAR and the Country Music Association.
“We are pleased to be able to extend DRIVE4COPD’s social media community through our platform, by promoting early diagnosis for those identified at risk by taking the DRIVE4COPD Population Screener,” John W. Walsh, COPD Foundation president and co-founder says.
The Population Screener is a 5-question test that helps individuals identify if they are at risk for COPD. After filling out the questions, they are encouraged to share their results with their healthcare professional.
“This Population Screener helps people identify their risk which in turn results in them being tested earlier for COPD, ultimately improving their quality of life,” Walsh says. “We look forward to continuing to support DRIVE4COPD in their mission to reach the missing millions across the U.S. by broadening our outreach and awareness.”
DRIVE4COPD is the nation's single largest awareness campaign for chronic obstructive pulmonary disease (COPD), the nation's fourth leading cause of death. Launched in February 2010 by Founding Sponsor Boehringer Ingelheim Pharmaceuticals, Inc., this landmark public health initiative is working to help people recognize the signs and symptoms of COPD, take action to see if they may be at risk and talk to their healthcare professional. DRIVE4COPD has been embraced by leading health, business, entertainment, and sports organizations with a common goal of driving fundamental change in COPD awareness in the United States.